| Filed | As-Of/On | Form | Fullname | Symbol | Country | Industry | Shares | Activity | Shares Change | Shares Pct. Change | Hypothetical Old Value | Hypothetical New Value | Hypothetical Value Chg. | Hypothetical Return | Hypothetical Results |
Director |
Other |
Ten Pct |
Officer |
Officer Title |
News Article |
History |
|---|
| 2009-11-10 | 2009-09-30 | 13F-HR | Xenoport Inc | XNPT | US | Medical-Drugs | 403,695 | Added More | 200,000 | 98.18 % | $6,539,859 | $6,600,413 | $60,554 | 0.92 % | $30,000 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Xenoport Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Viropharma Inc | VPHM | US | Medical-Drugs | 9,405,977 | No Change | 0 | 0 % | $71,955,724 | $72,426,023 | $470,299 | 0.65 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Viropharma Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Via Pharmaceuticals Inc | VIAP | US | Therapeutics | 102,881 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Via Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Trimeris Inc | TRMS | US | Therapeutics | 3,461,175 | No Change | 0 | 0 % | $12,391,007 | $11,352,654 | $-1,038,353 | -8.37 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Trimeris Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Torreypines Therapeutics Inc | TPTX | US | Medical-Biomedical/Gene | 33,546 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Torreypines Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Threshold Pharmaceuticals Inc | THLD | US | Therapeutics | 1,504,711 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Threshold Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Targacept Inc | TRGT | US | Medical-Drugs | 530,355 | Added More | 105,282 | 24.76 % | $11,386,722 | $11,826,917 | $440,195 | 3.86 % | $87,384 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Targacept Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Supergen Inc | SUPG | US | Medical-Biomedical/Gene | 331,480 | No Change | 0 | 0 % | $808,811 | $901,626 | $92,814 | 11.47 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Supergen Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Sucampo Pharmaceuticals Inc | SCMP | US | Medical-Drugs | 64,387 | No Change | 0 | 0 % | $262,055 | $238,876 | $-23,179 | -8.84 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Sucampo Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Senomyx Inc | SNMX | US | Research And Development | 34,114 | No Change | 0 | 0 % | $129,292 | $119,058 | $-10,234 | -7.91 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Senomyx Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Seattle Genetics Inc | SGEN | US | Medical-Biomedical/Gene | 15,970,287 | Added More | 1,880,000 | 13.34 % | $149,162,481 | $148,523,669 | $-638,811 | -0.42 % | $-75,200 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Seattle Genetics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Salix Pharmaceuticals Ltd | SLXP | US | Medical-Drugs | 4,801,442 | No Change | 0 | 0 % | $96,412,955 | $112,401,757 | $15,988,802 | 16.58 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-11-10 | 2009-09-30 | 13F-HR | Pharmasset Inc | VRUS | US | Medical-Drugs | 90,147 | Added More | 23,900 | 36.07 % | $1,930,047 | $1,772,290 | $-157,757 | -8.17 % | $-41,825 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Pharmasset Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Pharmathene Inc | PIP | US | Medical-Biomedical/Gene | 838,175 | No Change | 0 | 0 % | $3,059,339 | $2,916,849 | $-142,490 | -4.65 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Pharmathene Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Optimer Pharmaceuticals Inc | OPTR | US | Medical-Biomedical/Gene | 0 | Sold All | -187,926 | -100 % | - | - | - | -2.83 % | $65,774 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Optimer Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 200,000 | New Holding | 200,000 | 100 % | $5,432,000 | $5,598,000 | $166,000 | 3.05 % | $166,000 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Neurogen Corp | NRGN | US | Therapeutics | 8,205,406 | No Change | 0 | 0 % | $1,312,865 | $1,394,919 | $82,054 | 6.25 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Neurogen Corp |
| 2009-11-10 | 2009-09-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 0 | Sold All | -102,705 | -100 % | - | - | - | -1.04 % | $25,676 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Myriad Genetics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Metabasis Therapeutics Inc | MBRX | US | Medical-Biomedical/Gene | 2,018,903 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Metabasis Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Medarex Inc | MEDX | US | Therapeutics | 0 | Sold All | -569,289 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Medarex Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 1,472,782 | Sold Some | -366,547 | -19.92 % | $21,104,966 | $15,891,318 | $-5,213,648 | -24.70 % | $1,297,576 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Intermune Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Inspire Pharmaceuticals Inc | ISPH | US | Therapeutics | 3,608,190 | Added More | 1,800,000 | 99.54 % | $18,365,687 | $18,185,278 | $-180,410 | -0.98 % | $-90,000 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Inspire Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Inhibitex Inc | INHX | US | Medical-Biomedical/Gene | 620,904 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Inhibitex Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Infinity Pharmaceuticals Inc | INFI | US | Medical-Drugs | 220,973 | Sold Some | -171,001 | -43.62 % | $1,215,352 | $1,314,789 | $99,438 | 8.18 % | $-76,950 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Infinity Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Incyte Corp Ltd | INCY | US | Medical-Biomedical/Gene | 13,173,417 | Added More | 2,000,000 | 17.89 % | $100,249,703 | $99,459,298 | $-790,405 | -0.78 % | $-120,000 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Incyte Corp Ltd |
| 2009-11-10 | 2009-09-30 | 13F-HR | Immunomedics Inc | IMMU | US | Medical-Biomedical/Gene | 47,704 | No Change | 0 | 0 % | $166,964 | $169,349 | $2,385 | 1.42 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Immunomedics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Immunogen Inc | IMGN | US | Medical-Biomedical/Gene | 364,279 | Sold Some | -139,955 | -27.75 % | $2,877,804 | $3,041,730 | $163,926 | 5.69 % | $-62,980 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Immunogen Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Icagen Inc | ICGN | US | Medical-Drugs | 46,373 | No Change | 0 | 0 % | $21,795 | $22,259 | $464 | 2.12 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Icagen Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Human Genome Sciences Inc | HGSI | US | Medical-Biomedical/Gene | 1,637,988 | New Holding | 1,637,988 | 100 % | $46,764,557 | $44,848,111 | $-1,916,446 | -4.09 % | $-1,916,446 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Human Genome Sciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Inverness Medical Innovations Inc | IMA | US | Diagnostic Kits | 1,393,286 | Added More | 60,500 | 4.53 % | $57,222,256 | $57,960,698 | $738,442 | 1.29 % | $32,065 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Inverness Medical Innovations Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Halozyme Therapeutics Inc | HALO | US | Medical-Biomedical/Gene | 1,969,512 | No Change | 0 | 0 % | $12,073,109 | $12,545,791 | $472,683 | 3.91 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Genomic Health Inc | GHDX | US | Medical-Biomedical/Gene | 5,572,425 | Added More | 189,344 | 3.51 % | $111,392,776 | $107,492,078 | $-3,900,698 | -3.50 % | $-132,541 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Genomic Health Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Depomed Inc | DEPO | US | Drug Delivery Systems | 183,145 | No Change | 0 | 0 % | $578,738 | $604,379 | $25,640 | 4.43 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Depomed Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 701,579 | Added More | 130,000 | 22.74 % | $20,605,375 | $19,651,228 | $-954,147 | -4.63 % | $-176,800 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Dendreon Corp |
| 2009-11-10 | 2009-09-30 | 13F-HR | Curagen Corp | CRGN | US | Medical-Biomedical/Gene | 0 | Sold All | -388,613 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Curagen Corp |
| 2009-11-10 | 2009-09-30 | 13F-HR | Critical Therapeutics Inc | CRTX | US | Therapeutics | 112,337 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Critical Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Chelsea Therapeutics International Inc | CHTP | US | Medical-Drugs | 1,361,263 | Added More | 225,000 | 19.80 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Chelsea Therapeutics International Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 0 | Sold All | -399,119 | -100 % | - | - | - | 2.34 % | $-502,890 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Celgene Corp |
| 2009-11-10 | 2009-09-30 | 13F-HR | Cadence Pharmaceuticals Inc | CADX | US | Medical-Drugs | 636,215 | No Change | 0 | 0 % | $6,063,129 | $5,535,071 | $-528,058 | -8.70 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Biocryst Pharmaceuticals Inc | BCRX | US | Medical-Biomedical/Gene | 5,563,615 | No Change | 0 | 0 % | $65,595,021 | $53,132,523 | $-12,462,498 | -18.99 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 4,579,518 | Added More | 444,800 | 10.75 % | $155,062,479 | $159,962,564 | $4,900,084 | 3.16 % | $475,936 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Autoimmune Inc | AIMM.OB | US | Medical-Biomedical/Gene | 13,050 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Autoimmune Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ardea Biosciences Inc | RDEA | US | Medical-Drugs | 5,146,589 | No Change | 0 | 0 % | $70,096,542 | $70,405,338 | $308,795 | 0.44 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Ardea Biosciences Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Anadys Pharmaceuticals Inc | ANDS | US | Therapeutics | 134,792 | No Change | 0 | 0 % | $296,542 | $295,194 | $-1,348 | -0.45 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Amylin Pharmaceuticals Inc | AMLN | US | Therapeutics | 1,272,700 | Sold Some | -1,061,627 | -45.47 % | $15,743,299 | $15,832,388 | $89,089 | 0.56 % | $-74,314 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Amicus Therapeutics Inc | FOLD | US | Medical-Drugs | 763,097 | Sold Some | -358,240 | -31.94 % | $3,243,162 | $2,922,662 | $-320,501 | -9.88 % | $150,461 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Amicus Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Alsius Corp | ALUS | US | Medical Instruments | 62,872 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Alsius Corp |
| 2009-11-10 | 2009-09-30 | 13F-HR | Allos Therapeutics Inc | ALTH | US | Therapeutics | 5,832,002 | Sold Some | -1,149,269 | -16.46 % | $35,575,212 | $35,925,132 | $349,920 | 0.98 % | $-68,956 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Allos Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Allergan Incunited States | AGN | US | Medical-Drugs | 0 | Sold All | -25,800 | -100 % | - | - | - | -2.76 % | $43,086 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Allergan Incunited States |
| 2009-11-10 | 2009-09-30 | 13F-HR | Adolor Corp | ADLR | US | Medical-Drugs | 4,522,772 | Added More | 880,934 | 24.18 % | $6,422,336 | $6,829,386 | $407,049 | 6.33 % | $79,284 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Adolor Corp |
| 2009-11-10 | 2009-09-30 | 13F-HR | Acorda Therapeutics Inc | ACOR | US | Medical-Biomedical/Gene | 1,193,821 | Sold Some | -23,414 | -1.92 % | $28,651,704 | $28,532,322 | $-119,382 | -0.41 % | $2,341 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Acorda Therapeutics Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Acadia Pharmaceuticals Inc | ACAD | US | Medical-Drugs | 0 | Sold All | -3,359,373 | -100 % | - | - | - | -15.82 % | $839,843 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Ap Pharma Inc | APPA | US | Drug Delivery Systems | 2,884,546 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Ap Pharma Inc |
| 2009-11-10 | 2009-09-30 | 13F-HR | Micromet Inc | MITI | DE | Medical-Biomedical/Gene | 2,995,608 | Sold Some | -58,209 | -1.90 % | $17,973,648 | $20,669,695 | $2,696,047 | 15.00 % | $-52,388 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Micromet Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Zymogenetics Inc | ZGEN | US | Medical-Drugs | 0 | Sold All | -582,500 | -100 % | - | - | - | 16.76 % | $-495,125 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Zymogenetics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Xenoport Inc | XNPT | US | Medical-Drugs | 203,695 | Sold Some | -340,576 | -62.57 % | $3,888,538 | $3,330,413 | $-558,124 | -14.35 % | $933,178 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Xenoport Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Viropharma Inc | VPHM | US | Medical-Drugs | 9,405,977 | Added More | 2,371,631 | 33.71 % | $64,430,942 | $72,426,023 | $7,995,080 | 12.40 % | $2,015,886 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Viropharma Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Via Pharmaceuticals Inc | VIAP | US | Therapeutics | 102,881 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Via Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Vanda Pharmaceuticals Inc | VNDA | US | Therapeutics | 0 | Sold All | -225,142 | -100 % | - | - | - | -22.23 % | $661,917 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Vanda Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Trimeris Inc | TRMS | US | Therapeutics | 3,461,175 | No Change | 0 | 0 % | $7,926,091 | $11,352,654 | $3,426,563 | 43.23 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Trimeris Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Torreypines Therapeutics Inc | TPTX | US | Medical-Biomedical/Gene | 33,546 | No Change | 0 | 0 % | $4,361 | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Torreypines Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Threshold Pharmaceuticals Inc | THLD | US | Therapeutics | 1,504,711 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Threshold Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Targacept Inc | TRGT | US | Medical-Drugs | 425,073 | No Change | 0 | 0 % | $5,389,926 | $9,479,128 | $4,089,202 | 75.86 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Targacept Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Symyx Technologies | SMMX | US | Chemicals-Specialty | 0 | Sold All | -73,127 | -100 % | - | - | - | -30.56 % | $137,479 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Symyx Technologies |
| 2009-08-17 | 2009-06-30 | 13F-HR | Supergen Inc | SUPG | US | Medical-Biomedical/Gene | 331,480 | No Change | 0 | 0 % | $861,848 | $901,626 | $39,778 | 4.61 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Supergen Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Sunesis Pharmaceuticals Inc | SNSS | US | Therapeutics | 0 | Sold All | -1,252,083 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Sunesis Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Sucampo Pharmaceuticals Inc | SCMP | US | Medical-Drugs | 64,387 | No Change | 0 | 0 % | $443,626 | $238,876 | $-204,751 | -46.15 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Sucampo Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Siga Technologies Inc | SIGA | US | Medical-Drugs | 0 | Sold All | -573,832 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Siga Technologies Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Senomyx Inc | SNMX | US | Research And Development | 34,114 | No Change | 0 | 0 % | $124,175 | $119,058 | $-5,117 | -4.12 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Senomyx Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Seattle Genetics Inc | SGEN | US | Medical-Biomedical/Gene | 14,090,287 | Added More | 1,178,163 | 9.12 % | $158,093,020 | $131,039,669 | $-27,053,351 | -17.11 % | $-2,262,073 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Seattle Genetics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Salix Pharmaceuticals Ltd | SLXP | US | Medical-Drugs | 4,801,442 | Added More | 987,046 | 25.87 % | $59,393,838 | $112,401,757 | $53,007,920 | 89.24 % | $10,896,988 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Salix Pharmaceuticals Ltd |
| 2009-08-17 | 2009-06-30 | 13F-HR | Pharmasset Inc | VRUS | US | Medical-Drugs | 66,247 | No Change | 0 | 0 % | $1,071,876 | $1,302,416 | $230,540 | 21.50 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Pharmasset Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Pharmathene Inc | PIP | US | Medical-Biomedical/Gene | 838,175 | New Holding | 838,175 | 100 % | $2,338,508 | $2,916,849 | $578,341 | 24.73 % | $578,341 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Pharmathene Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Optimer Pharmaceuticals Inc | OPTR | US | Medical-Biomedical/Gene | 187,926 | Sold Some | -236,325 | -55.70 % | $2,414,849 | $2,255,112 | $-159,737 | -6.61 % | $200,876 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Optimer Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Onyx Pharmaceuticals Inc | ONXX | US | Therapeutics | 0 | Sold All | -36,578 | -100 % | - | - | - | -6.41 % | $70,230 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Onyx Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Neurogen Corp | NRGN | US | Therapeutics | 8,205,406 | No Change | 0 | 0 % | $1,641,081 | $1,394,919 | $-246,162 | -15.00 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Neurogen Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Myriad Genetics Inc | MYGN | US | Medical-Biomedical/Gene | 102,705 | Added More | 20,539 | 24.99 % | $2,501,894 | $2,423,838 | $-78,056 | -3.11 % | $-15,610 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Myriad Genetics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Metabasis Therapeutics Inc | MBRX | US | Medical-Biomedical/Gene | 2,018,903 | Sold Some | -227,856 | -10.14 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Metabasis Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Medarex Inc | MEDX | US | Therapeutics | 569,289 | Added More | 275,000 | 93.44 % | $9,074,467 | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Medarex Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Intermune Inc | ITMN | US | Medical-Biomedical/Gene | 1,839,329 | No Change | 0 | 0 % | $25,934,539 | $19,846,360 | $-6,088,179 | -23.47 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Intermune Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Inspire Pharmaceuticals Inc | ISPH | US | Therapeutics | 1,808,190 | Sold Some | -1,591,571 | -46.81 % | $8,444,247 | $9,113,278 | $669,030 | 7.92 % | $-588,881 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Inspire Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Insmed Inc | INSM | US | Therapeutics | 0 | Sold All | -13,699 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Insmed Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Inhibitex Inc | INHX | US | Medical-Biomedical/Gene | 620,904 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Inhibitex Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Infinity Pharmaceuticals Inc | INFI | US | Medical-Drugs | 391,974 | Added More | 306,342 | 357.74 % | $2,532,152 | $2,332,245 | $-199,907 | -7.89 % | $-156,234 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Infinity Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Incyte Corp Ltd | INCY | US | Medical-Biomedical/Gene | 11,173,417 | No Change | 0 | 0 % | $68,604,780 | $84,359,298 | $15,754,518 | 22.96 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Incyte Corp Ltd |
| 2009-08-17 | 2009-06-30 | 13F-HR | Immunomedics Inc | IMMU | US | Medical-Biomedical/Gene | 47,704 | No Change | 0 | 0 % | $184,614 | $169,349 | $-15,265 | -8.26 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Immunomedics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Immunogen Inc | IMGN | US | Medical-Biomedical/Gene | 504,234 | No Change | 0 | 0 % | $3,600,231 | $4,210,354 | $610,123 | 16.94 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Immunogen Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Icagen Inc | ICGN | US | Medical-Drugs | 46,373 | No Change | 0 | 0 % | $31,997 | $22,259 | $-9,738 | -30.43 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Icagen Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Inverness Medical Innovations Inc | IMA | US | Diagnostic Kits | 1,332,786 | Added More | 60,000 | 4.71 % | $46,487,576 | $55,443,898 | $8,956,322 | 19.26 % | $403,200 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Inverness Medical Innovations Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Halozyme Therapeutics Inc | HALO | US | Medical-Biomedical/Gene | 1,969,512 | Sold Some | -45,000 | -2.23 % | $14,082,011 | $12,545,791 | $-1,536,219 | -10.90 % | $35,100 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Halozyme Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Genomic Health Inc | GHDX | US | Medical-Biomedical/Gene | 5,383,081 | Added More | 182,694 | 3.51 % | $107,769,282 | $103,839,632 | $-3,929,649 | -3.64 % | $-133,367 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Genomic Health Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Depomed Inc | DEPO | US | Drug Delivery Systems | 183,145 | No Change | 0 | 0 % | $628,187 | $604,379 | $-23,809 | -3.79 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Depomed Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Dendreon Corp | DNDN | US | Therapeutics | 571,579 | New Holding | 571,579 | 100 % | $12,649,043 | $16,009,928 | $3,360,885 | 26.57 % | $3,360,885 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Dendreon Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Cytokinetics Inc | CYTK | US | Medical-Biomedical/Gene | 0 | Sold All | -1,298,432 | -100 % | - | - | - | 22.30 % | $-805,028 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cytokinetics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Cyclacel Pharmaceuticals Inc | CYCC | US | Therapeutics | 0 | Sold All | -85,811 | -100 % | - | - | - | -20.79 % | $18,020 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cyclacel Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Curagen Corp | CRGN | US | Medical-Biomedical/Gene | 388,613 | No Change | 0 | 0 % | $536,286 | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Curagen Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Critical Therapeutics Inc | CRTX | US | Therapeutics | 112,337 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Critical Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Chelsea Therapeutics International Inc | CHTP | US | Medical-Drugs | 1,136,263 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Chelsea Therapeutics International Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Cepheid Inc | CPHD | US | Medical Instruments | 0 | Sold All | -60,100 | -100 % | - | - | - | 9.95 % | $-72,721 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cepheid Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Celgene Corp | CELG | US | Medical-Biomedical/Gene | 399,119 | Sold Some | -208,900 | -34.35 % | $20,790,109 | $21,915,624 | $1,125,516 | 5.41 % | $-589,098 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Celgene Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Cadence Pharmaceuticals Inc | CADX | US | Medical-Drugs | 636,215 | Sold Some | -1,447 | -0.22 % | $6,336,701 | $5,535,071 | $-801,631 | -12.65 % | $1,823 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Cadence Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Biomarin Pharmaceutical Inc | BMRN | US | Therapeutics | 0 | Sold All | -167,946 | -100 % | - | - | - | 12.23 % | $-310,700 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Biomarin Pharmaceutical Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Biocryst Pharmaceuticals Inc | BCRX | US | Medical-Biomedical/Gene | 5,563,615 | Sold Some | -817,074 | -12.80 % | $52,909,979 | $53,132,523 | $222,545 | 0.42 % | $-32,683 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Biocryst Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Auxilium Pharmaceuticals Inc | AUXL | US | Medical-Drugs | 4,134,718 | Added More | 23,590 | 0.57 % | $116,640,395 | $144,425,700 | $27,785,305 | 23.82 % | $158,525 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Auxilium Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Autoimmune Inc | AIMM.OB | US | Medical-Biomedical/Gene | 13,050 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Autoimmune Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Ariad Pharmaceuticals Inc | ARIA | US | Medical-Biomedical/Gene | 0 | Sold All | -1,965,713 | -100 % | - | - | - | 3.34 % | $-137,600 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Ariad Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Ardea Biosciences Inc | RDEA | US | Medical-Drugs | 5,146,589 | No Change | 0 | 0 % | $101,799,530 | $70,405,338 | $-31,394,193 | -30.83 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Ardea Biosciences Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Anadys Pharmaceuticals Inc | ANDS | US | Therapeutics | 134,792 | Sold Some | -513,694 | -79.21 % | $301,934 | $295,194 | $-6,740 | -2.23 % | $25,685 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Anadys Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Amylin Pharmaceuticals Inc | AMLN | US | Therapeutics | 2,334,327 | New Holding | 2,334,327 | 100 % | $30,299,564 | $29,039,028 | $-1,260,537 | -4.16 % | $-1,260,537 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Amylin Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Amicus Therapeutics Inc | FOLD | US | Medical-Drugs | 1,121,337 | Sold Some | -180,667 | -13.87 % | $11,011,529 | $4,294,721 | $-6,716,809 | -60.99 % | $1,082,195 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Amicus Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Altus Pharmaceuticals Inc | ALTU | US | Therapeutics | 0 | Sold All | -70,494 | -100 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Altus Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Alsius Corp | ALUS | US | Medical Instruments | 62,872 | No Change | 0 | 0 % | - | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Alsius Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Allos Therapeutics Inc | ALTH | US | Therapeutics | 6,981,271 | Sold Some | -1,019,859 | -12.74 % | $49,985,900 | $43,004,629 | $-6,981,271 | -13.96 % | $1,019,859 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Allos Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Allergan Incunited States | AGN | US | Medical-Drugs | 25,800 | No Change | 0 | 0 % | $1,389,846 | $1,512,396 | $122,550 | 8.81 % | $0 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Allergan Incunited States |
| 2009-08-17 | 2009-06-30 | 13F-HR | Adolor Corp | ADLR | US | Medical-Drugs | 3,641,838 | Added More | 3,407,323 | 1452.92 % | $5,826,941 | $5,499,175 | $-327,765 | -5.62 % | $-306,659 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Adolor Corp |
| 2009-08-17 | 2009-06-30 | 13F-HR | Acorda Therapeutics Inc | ACOR | US | Medical-Biomedical/Gene | 1,217,235 | Added More | 13,152 | 1.09 % | $28,154,646 | $29,091,917 | $937,271 | 3.32 % | $10,127 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Acorda Therapeutics Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Acadia Pharmaceuticals Inc | ACAD | US | Medical-Drugs | 3,359,373 | Added More | 423,953 | 14.44 % | $19,249,207 | $4,467,966 | $-14,781,241 | -76.78 % | $-1,865,393 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Acadia Pharmaceuticals Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Ap Pharma Inc | APPA | US | Drug Delivery Systems | 2,884,546 | No Change | 0 | 0 % | $2,451,864 | - | - | - % | | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Ap Pharma Inc |
| 2009-08-17 | 2009-06-30 | 13F-HR | Novo Nordisk As | NVO | DK | Medical-Drugs | 0 | Sold All | -295,646 | -100 % | - | - | - | 9.84 % | $-1,753,181 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Novo Nordisk As |
| 2009-08-17 | 2009-06-30 | 13F-HR | Micromet Inc | MITI | DE | Medical-Biomedical/Gene | 3,053,817 | Sold Some | -670,768 | -18.00 % | $18,048,058 | $21,071,337 | $3,023,279 | 16.75 % | $-664,060 | | | | | | News Article | History of Baker Bros Advisors Llc Ownership Of Micromet Inc |